Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 18/20 | 0.51 |
| ▸ | CYP11B2 | P19099 | 18/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13559004 | 0.93 | CYP11B1 (0.45) | CYP11B1CYP11B2CYP3A4 | |
| SCHEMBL21251416 | 0.83 | CYP11B1 (0.57) | CYP11B1CYP11B2CYP3A4 | |
| SCHEMBL19540958 | 0.81 | CYP11B1 (0.51) | CYP11B1CYP11B2CYP3A4 | |
| SCHEMBL22474091 | 0.81 | CYP11B1 (0.64) | CYP11B1CYP11B2CYP3A4 | |
| SCHEMBL3588189 | 0.80 | IDH1 (0.46) | CYP11B1CYP11B2 | |
| Hydrochloric Acid SCHEMBL26136027 | 0.79 | CYP11B1 (0.62) | CYP11B1CYP11B2CYP3A4 | |
| SCHEMBL20179618 | 0.78 | TUBB4A (0.47) | CYP11B1CYP11B2CYP3A4 | |
| SCHEMBL24225 | 0.77 | — | — | |
| SCHEMBL22180869 | 0.77 | CYP11B1 (0.44) | CYP11B1CYP11B2CYP3A4 | |
| SCHEMBL30768308 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230138901-A1 | COMPOUND HAVING KHK INHIBITORY EFFECT | HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD. (CN) | 2023-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230138901-A1 | COMPOUND HAVING KHK INHIBITORY EFFECT | KHK, KHDRBS1, KHSRP | CYP11B1 626/4885CYP11B2 614/4885CYP3A4 4641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.